Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Open-market sale General Counsel sold 899 shares at $3.78 ($3,398)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 424B5 Offering Prospectus
  7. 8-K Event Material agreement
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Open-market buy Director bought 100,000 shares at an average $1.85 ($184,613)
  20. 8-K Event Other events

Page 5 of 38 · 755 filings